novo nordisk glp-1 patent litigation drops lawsuit against Hims & Hers over off-brand weight loss medications, enter collaboration Novo Nordisk sues Eli Lilly

BMI is calculated by dividing a persons weight in kilograms by the square of their height in meters, providing a standardized measure of body fatness

Nasal spray preparation may include stabilizers extending room temperature viability

Across the European region, the prevalence of obesity is projected to be 29.42% in men and 29.97% in women in 2030, with an estimated 102 million men and 113 million women at risk of the complications of obesity

Sources: SAHPRA, NHS, World Health Organization.

Despite the emergence of newer drugs like GLP-1 receptor agonists, appetite suppressants remain essential for initiating weight loss and supporting behavioral changes in weight management strategies

Never mix different peptides in the same vial unless the specific combination has been validated